Physician profile
Mark Feger
NPI 1689237869
$13,472.58
in general payments reported to CMS, 2019-2025
11 companies · $3,171 in 2025
The $3,171 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $6,422 · 2022: $201 · 2023: $161 · 2024: $3,517 · 2025: $3,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,976 · Travel and Lodging: $2,373 · Grant: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,975.76 |
| Travel and Lodging | $2,373.21 |
| Grant | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $6,438.29 | 2020-2024 | |
| Medtronic, INC. | $3,409.72 | 2022-2025 | Infuse Bone Graft, Unid_pass, Mazor X System |
| Stryker Corporation | $1,285.71 | 2024-2025 | Aero-Ll, N/A, Tritanium |
| Medical Device Business Services, INC. | $847.67 | 2025 | Teligen |
| Globus Medical, INC. | $533.29 | 2024-2025 | Excelsius Gps, Modulus, Altera |
| Depuy Synthes Sales INC. | $426.86 | 2024-2025 | Symphony, Attune, Trialtis |
| Cerapedics INC. | $173.87 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Alphatec Spine, INC | $161.52 | 2024-2025 | Other - Miscellaneous, Invictus Mis |
| Kuros Biosciences USA, INC | $113.02 | 2024 | Magnetos |
| Osteocentric Technologies, INC. | $45.42 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Biocomposites INC | $37.21 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Feger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.